Hims & Hers Health (HIMS) Net Cash Flow (2019 - 2026)
Hims & Hers Health (HIMS) reported Net Cash Flow of -$4.0 million for Q1 2026, down 107.45% on a YoY basis from $53.3 million in Q1 2025, and up 96.69% sequentially from -$119.9 million in Q4 2025.
Hims & Hers Health (HIMS) Net Cash Flow (2019 - 2026) Analysis & Trends
Hims & Hers Health (HIMS) has 8 years of Net Cash Flow data on file, last reported at -$4.0 million in Q1 2026.
- For the quarter ending Q1 2026, Net Cash Flow fell 107.45% year-over-year to -$4.0 million; the trailing twelve-month figure through Mar 2026 stood at -$52.6 million (down 131.13% YoY), and the FY2025 full-year result was $4.7 million, down 96.24% from the prior year.
- Net Cash Flow grew to -$4.0 million in Q1 2026, from -$119.9 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $849.0 million in Q2 2025 to a low of -$777.7 million in Q3 2025.
- A 5-year average of $8.8 million and a median of $6.8 million in 2022 frame the typical range for Net Cash Flow.
- Peak annual rise in Net Cash Flow reached 3428.68% in 2025, while the deepest fall reached 2258.26% in 2025.
- Tracing HIMS's Net Cash Flow over 5 years: stood at -$11.2 million in 2022, then surged by 446.44% to $38.7 million in 2023, then jumped by 43.43% to $55.5 million in 2024, then plunged by 315.91% to -$119.9 million in 2025, then surged by 96.69% to -$4.0 million in 2026.
- Business Quant data shows HIMS's Net Cash Flow at -$4.0 million in Q1 2026, -$119.9 million in Q4 2025, and -$777.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 202.00 Mn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | -526.00 Mn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 711.50 Mn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | -277.40 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 461.90 Mn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | -446.50 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | -112.00 Mn |
| 10 | Hims & Hers Health | 6.44 Bn | 5.69 Bn | 396.79 Mn | -3.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.97 Mn |
| Mar 31, 2026 | -3.97 Mn |
| Dec 31, 2025 | -119.89 Mn |
| Dec 31, 2025 | -119.89 Mn |
| Sep 30, 2025 | -777.69 Mn |
| Sep 30, 2025 | -777.69 Mn |
| Jun 30, 2025 | 848.96 Mn |
| Jun 30, 2025 | 848.96 Mn |
| Mar 31, 2025 | 53.28 Mn |
| Mar 31, 2025 | 53.28 Mn |
| Dec 31, 2024 | 55.53 Mn |
| Dec 31, 2024 | 55.53 Mn |
| Sep 30, 2024 | 36.03 Mn |
| Sep 30, 2024 | 36.03 Mn |
| Jun 30, 2024 | 24.06 Mn |
| Jun 30, 2024 | 24.06 Mn |
| Mar 31, 2024 | 8.57 Mn |
| Mar 31, 2024 | 8.57 Mn |
| Dec 31, 2023 | 38.72 Mn |
| Dec 31, 2023 | 38.72 Mn |